Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

ClinicalTrials.gov ID: NCT01240538

Public ClinicalTrials.gov record NCT01240538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Dose Escalation Study of Reolysin, a Replication Competent Reovirus, in Pediatric Patients With Relapsed or Refractory Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase I trial studies the side effects and the best dose of viral therapy in treating young patients with solid tumors that have come back or that have not responded to standard therapy. Some tumors have cells with a genetic weakness that makes them unable to fight off a virus called wild-type reovirus. The virus causes cells with this weakness to die, and may therefore be able to kill tumor cells without damaging normal cells. Cyclophosphamide is a drug used in chemotherapy that stops tumor cells from dividing and causes them to die. Giving wild-type reovirus together with cyclophosphamide may kill more tumor cells.

Study identification

NCT ID
NCT01240538
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
26 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2010 (Type not available)
Primary completion
Apr 2014 (Actual)
Completion
Not listed
Last update posted
May 13, 2014

Started 2010

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
24
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Phoenix Childrens Hospital Phoenix Arizona 85016 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Childrens Hospital of Orange County Orange California 92868-3874 —
University of California San Francisco Medical Center-Parnassus San Francisco California 94143 —
Alfred I duPont Hospital for Children Wilmington Delaware 19803 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Children's Clinic - Jacksonville Jacksonville Florida 32207-8426 —
Lurie Children's Hospital-Chicago Chicago Illinois 60614 —
Indiana University Medical Center Indianapolis Indiana 46202 —
Riley Hospital for Children Indianapolis Indiana 46202 —
C S Mott Children's Hospital Ann Arbor Michigan 48109 —
University of Minnesota Medical Center-Fairview Minneapolis Minnesota 55455 —
Columbia University Medical Center New York New York 10032 —
Montefiore Medical Center The Bronx New York 10467-2490 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Oregon Health and Science University Portland Oregon 97239 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Baylor College of Medicine Houston Texas 77030 —
Seattle Children's Hospital Seattle Washington 98105 —
Midwest Children's Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01240538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2014 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01240538 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →